Predicting survival of cancer patients by chromosomal copy number heterogeneity

We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

Detalles Bibliográficos
Autores principales: Van Den Bosch, Tom, van Dijk, Erik, Vermeulen, Louis, Miedema, Daniël M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Author’s Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489936/
https://www.ncbi.nlm.nih.gov/pubmed/34616875
http://dx.doi.org/10.1080/23723556.2021.1949956
_version_ 1784578424916934656
author Van Den Bosch, Tom
van Dijk, Erik
Vermeulen, Louis
Miedema, Daniël M.
author_facet Van Den Bosch, Tom
van Dijk, Erik
Vermeulen, Louis
Miedema, Daniël M.
author_sort Van Den Bosch, Tom
collection PubMed
description We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.
format Online
Article
Text
id pubmed-8489936
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-84899362021-10-05 Predicting survival of cancer patients by chromosomal copy number heterogeneity Van Den Bosch, Tom van Dijk, Erik Vermeulen, Louis Miedema, Daniël M. Mol Cell Oncol Author’s Views We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance. Taylor & Francis 2021-08-03 /pmc/articles/PMC8489936/ /pubmed/34616875 http://dx.doi.org/10.1080/23723556.2021.1949956 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Author’s Views
Van Den Bosch, Tom
van Dijk, Erik
Vermeulen, Louis
Miedema, Daniël M.
Predicting survival of cancer patients by chromosomal copy number heterogeneity
title Predicting survival of cancer patients by chromosomal copy number heterogeneity
title_full Predicting survival of cancer patients by chromosomal copy number heterogeneity
title_fullStr Predicting survival of cancer patients by chromosomal copy number heterogeneity
title_full_unstemmed Predicting survival of cancer patients by chromosomal copy number heterogeneity
title_short Predicting survival of cancer patients by chromosomal copy number heterogeneity
title_sort predicting survival of cancer patients by chromosomal copy number heterogeneity
topic Author’s Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489936/
https://www.ncbi.nlm.nih.gov/pubmed/34616875
http://dx.doi.org/10.1080/23723556.2021.1949956
work_keys_str_mv AT vandenboschtom predictingsurvivalofcancerpatientsbychromosomalcopynumberheterogeneity
AT vandijkerik predictingsurvivalofcancerpatientsbychromosomalcopynumberheterogeneity
AT vermeulenlouis predictingsurvivalofcancerpatientsbychromosomalcopynumberheterogeneity
AT miedemadanielm predictingsurvivalofcancerpatientsbychromosomalcopynumberheterogeneity

Ejemplares similares